CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in TNYA — Tenaya Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in TNYA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$34,600
-$1,000 QoQ
Shares Held
50,000
0.0% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 103 holders
Holding Since
Sep 2021
18 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TNYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,184,692,793 across 287 Biotechnology names. TNYA ranks #283 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in TNYA
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $34,600 | 50,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $35,600 | 50,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $81,000 | 50,000 | Shares | Sole | 2025-11-10 | |
| 2025-03-31 | $74,209 | 130,192 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $218,200 | 152,588 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $294,494 | 152,588 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $473,022 | 152,588 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $670,067 | 128,120 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $387,283 | 119,532 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $304,806 | 119,532 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $701,652 | 119,532 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $322,144 | 113,033 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $123,416 | 61,401 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $192,380 | 66,338 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $373,482 | 66,338 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $809,333 | 68,704 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $673,539 | 35,543 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $706,457 | 34,211 | Shares | Sole | 2021-11-16 | |
| No filing history on record for this holder in this stock. | ||||||